Clinical Trial Update: STRIVE (Sierra Leone Trial to Introduce a Vaccine Against Ebola) [Phase 2, Phase 3]

View source ↗

Summary

STRIVE in Sierra Leone completed Phase 2/3 evaluation of two Ebola vaccines (rVSV-ZEBOV and ChAd3-EBO-Z) with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ebola Virus Disease

Drugs mentioned

• ChAd3-EBO-Z
• Ervebo (rVSVΔG-ZEBOV-GP)

Snippet

Sponsor: Centers for Disease Control and Prevention | Conditions: Hemorrhagic Fever, Ebola | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2018-04-05